Background: Diabetes Mellitus was considered one of the most alarming pandemics of the twenty-first century before the advent of the COVID-19 pandemic. Glibenclamide (glyburide) is an anti-DM drug of the sulfonylurea class. Several studies have examined one of the medicinal plants, black seed (nigella sativa) as a complementary treatment in the control of DM.Objective: This study determine the effect of the combination of black seed (nigella sativa) and glibenclamide on reducing blood glucose levels.Methods: This research design was an experiment using a pretest posttest design with control group design. This study used 24 mice (mus muscullus) which were divided into 4 groups, namely a negative control group that was only given aquadest, a positive control group that was given alloxane as an induction of hyperglycemia and anti-DM drug glibenclamide, treatment group 1 was given aloxane and Black Seed, and treatment group 2 was given alloxane and a combination of black seed and glibenclamid. Data were analyzed using the Paired T Test with α = 0.05.Results: Blood glucose levels in the black seed and glibenclamid combination treatment group decreased significantly (p=0,00).Conclusion: the combination of black seed (nigella sativa) and glibenclamide is effective in lowering glucose levels.
No takes yet. Share an insight, caveat, or question.
Wardani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: